诚达药业 (301201.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

61.1x

Market Cap

CNY 5.33B

MomentumView details →

1D Return

−3.83%

YTD Return

−13.12%

RSI (14)

50.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

61.1x

Market Cap

CNY 5.33B

RSI (14)

50.2

MomentumView details →

1D Return

−3.83%

YTD Return

−13.12%

ProfitabilityView details →

Gross Margin

40.43%

Net Margin

−0.77%

EBITDA Margin

18.15%

ROE (TTM)

−0.17%

ROA (TTM)

−0.15%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

+48.54%

EPS YoY

+92.69%

FCF YoY

+95.76%

Revenue CAGR 3Y

−0.41%

EPS CAGR 3Y

+57.44%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

7.57x

Quick Ratio

6.72x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

458.30M

Net Income (TTM)

−3.52M

Op. CF (TTM)

45.57M

Latest newsMore news →

Chengda Pharmaceutical announced its H1 2026 results: revenue of 255 million yuan, up 40.03% year-on-year; net profit attributable to shareholders of 2.2997 million yuan, down 82.07% year-on-year; net loss attributable to shareholders excluding non-recurring items of 5.2726 million yuan, down 281.87% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.11d ago

Similar companies

赞宇科技002637.SZ 英威腾002334.SZ 远信工业301053.SZ 凯伦股份300715.SZ 粤海饲料001313.SZ 蓝英装备300293.SZ

Latest newsMore news →

Chengda Pharmaceutical announced its H1 2026 results: revenue of 255 million yuan, up 40.03% year-on-year; net profit attributable to shareholders of 2.2997 million yuan, down 82.07% year-on-year; net loss attributable to shareholders excluding non-recurring items of 5.2726 million yuan, down 281.87% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.11d ago